Blomjous C E, Schipper N W, Baak J P, van Galen E M, de Voogt H J, Meyer C J
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
J Clin Pathol. 1988 Jan;41(1):21-5. doi: 10.1136/jcp.41.1.21.
Cellular DNA content was determined by flow cytometry on routinely processed paraffin sections of 61 primary and untreated transitional cell carcinomas of the urinary bladder, and correlated with tumour grade and stage and clinical follow up. All 16 (25%) grade 1 carcinomas were diploid and all 11 (20%) grade 3 tumours were aneuploid. The 34 (55%) grade 2 carcinomas comprised 13 (40%) diploid and 21 (60%) aneuploid cases. Among the 37 superficial carcinomas (stage Ta and T1), 25 (65%) were diploid; 20 (85%) of the 24 advanced tumours (stage T2 to T4) had aneuploid tracings. Ploidy was a significant prognostic indicator (p: 0.006) of five year survival. The initial presence of aneuploidy in superficial bladder carcinoma (stage Ta and T1) is a strong argument for more aggressive treatment than is customary.
通过流式细胞术对61例未经治疗的原发性膀胱移行细胞癌常规处理的石蜡切片进行细胞DNA含量测定,并将其与肿瘤分级、分期及临床随访结果相关联。所有16例(25%)1级癌均为二倍体,所有11例(20%)3级肿瘤均为非整倍体。34例(55%)2级癌包括13例(40%)二倍体和21例(60%)非整倍体病例。在37例浅表性癌(Ta期和T1期)中,25例(65%)为二倍体;24例进展期肿瘤(T2期至T4期)中有20例(85%)出现非整倍体图谱。倍性是五年生存率的一个重要预后指标(p:0.006)。浅表性膀胱癌(Ta期和T1期)最初出现非整倍体有力地支持了比常规治疗更积极的治疗方法。